Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0V3DO
|
||||
| Former ID |
DNC013667
|
||||
| Drug Name |
1,2-Bis-[R-(-)-apomorphine-2'-oxy]ethane
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529349] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C36H36N2O6
|
||||
| Canonical SMILES |
CN1CCC2=C3C1CC4=C(C3=CC(=C2)OCCOC5=CC6=C7C(CC8=C(C7=C5)<br />C(=C(C=C8)O)O)N(CC6)C)C(=C(C=C4)O)O
|
||||
| InChI |
1S/C36H36N2O6/c1-37-9-7-21-13-23(17-25-31(21)27(37)15-19-3-5-29(39)35(41)33(19)25)43-11-12-44-24-14-22-8-10-38(2)28-16-20-4-6-30(40)36(42)34(20)26(18-24)32(22)28/h3-6,13-14,17-18,27-28,39-42H,7-12,15-16H2,1-2H3/t27-,28-/m1/s1
|
||||
| InChIKey |
KWKONXOZQQYOJW-VSGBNLITSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | D(2) dopamine receptor | Target Info | Inhibitor | [529349] | |
| Dopamine D1 receptor | Target Info | Inhibitor | [529349] | ||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Dopamine receptor mediated signaling pathway | |||||
| Nicotine pharmacodynamics pathwayP05912:Dopamine receptor mediated signaling pathway | |||||
| PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.